Free Trial

Short Interest in Global Medical REIT Inc. (NYSE:GMRE) Grows By 8.6%

Global Medical REIT logo with Finance background

Global Medical REIT Inc. (NYSE:GMRE - Get Free Report) was the target of a significant growth in short interest in January. As of January 15th, there was short interest totalling 1,140,000 shares, a growth of 8.6% from the December 31st total of 1,050,000 shares. Based on an average daily trading volume, of 444,500 shares, the days-to-cover ratio is presently 2.6 days.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank assumed coverage on shares of Global Medical REIT in a research note on Friday, October 18th. They set a "buy" rating and a $11.75 target price on the stock.

Check Out Our Latest Stock Analysis on Global Medical REIT

Global Medical REIT Stock Up 0.6 %

GMRE stock traded up $0.04 during mid-day trading on Wednesday, reaching $7.93. 291,640 shares of the company traded hands, compared to its average volume of 512,758. The stock has a market cap of $529.99 million, a price-to-earnings ratio of -396.50, a P/E/G ratio of 1.33 and a beta of 1.24. Global Medical REIT has a fifty-two week low of $7.33 and a fifty-two week high of $10.46. The firm's 50 day moving average price is $8.07 and its 200 day moving average price is $8.88. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26.

Global Medical REIT (NYSE:GMRE - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.18). The company had revenue of $34.26 million for the quarter, compared to the consensus estimate of $34.88 million. Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. During the same quarter last year, the company posted $0.23 EPS. As a group, equities research analysts predict that Global Medical REIT will post 0.81 EPS for the current fiscal year.

Global Medical REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, January 8th. Investors of record on Friday, December 20th were given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 10.59%. The ex-dividend date of this dividend was Friday, December 20th. Global Medical REIT's payout ratio is currently -4,197.90%.

Institutional Investors Weigh In On Global Medical REIT

A number of institutional investors have recently added to or reduced their stakes in GMRE. Quantinno Capital Management LP bought a new position in shares of Global Medical REIT during the 3rd quarter valued at approximately $138,000. Zacks Investment Management boosted its stake in Global Medical REIT by 12.9% during the third quarter. Zacks Investment Management now owns 14,803 shares of the company's stock valued at $147,000 after buying an additional 1,696 shares during the period. Intech Investment Management LLC purchased a new stake in Global Medical REIT in the third quarter valued at approximately $150,000. Proficio Capital Partners LLC bought a new stake in shares of Global Medical REIT during the 4th quarter worth $178,000. Finally, Entropy Technologies LP purchased a new position in Global Medical REIT in the fourth quarter worth $179,000. 57.52% of the stock is owned by institutional investors.

About Global Medical REIT

(Get Free Report)

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Featured Stories

Should You Invest $1,000 in Global Medical REIT Right Now?

Before you consider Global Medical REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.

While Global Medical REIT currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines